全球周邊支架與植入市場

到 2030 年，全球周邊支架植入市場將達到 56 億美元

全球周邊支架和植入市場規模預計在2024年為40億美元，預計到2030年將達到56億美元，2024年至2030年的複合年成長率為6.0%。裸金屬支架是本報告分析的細分市場之一，預計其複合年成長率為6.8%，到分析期結束時規模將達到33億美元。覆膜支架細分市場在分析期間的複合年成長率預計為5.2%。

美國市場規模估計為 11 億美元，中國市場預期複合年成長率為 9.6%

美國外周支架植入市場規模預計2024年達到11億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到12億美元，在2024-2030年的分析期間內，複合年成長率為9.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.9%和5.9%。在歐洲，預計德國市場的複合年成長率為3.9%。

全球周邊支架和植入市場—主要趨勢和促進因素摘要

為什麼周邊支架植入對於恢復動脈疾病的血流至關重要？

周邊支架植入是一種用於疏通肢體狹窄或阻塞動脈的醫療設備，尤其適用於周邊動脈疾病(PAD)。這些支架提供結構支撐，保持血管暢通，恢復血液循環，並預防組織缺血和截肢等併發症。支架經由導管植入，是一種微創的外科搭橋手術治療方法。

由於周邊動脈疾病 (PAD) 與糖尿病、吸菸和老齡化密切相關，置入術已成為治療方法，因為傳統的血管成形術可能無法保證這些部位的長期通暢。支架設計和置入技術的不斷改進正在提高支架的耐用性和患者預後。

科技如何發展以提高功效和安全性？

支架創新的重點在於提高徑向強度、柔韌性和長期通暢性，同時最大限度地減少血管再阻塞和骨折。鎳鈦合金基自動擴張型支架因其對運動和血管壓縮的適應性，廣泛應用於周邊血管。藥物釋放型支架 (DES) 和藥物塗層支架 (DCS) 可釋放紫杉醇等抗增殖藥物，以降低血管再阻塞風險。

生物可吸收支架仍在評估中，但有望提供臨時錨固，同時減少長期併發症。改進的支架輸送系統、更細的導管以及影像輔助置入工具正在提高手術的精確度。此外，專為複雜解剖結構（例如膝下動脈 (BTK)）設計的新型支架正在支持治療適應症的擴展。

市場成長集中在哪裡以及哪些條件推動了採用？

血管外科中心、導管室和先進醫療體系的介入放射科的發展最為迅速。北美和歐洲憑藉其完善的周邊動脈疾病 (PAD)篩檢和介入基礎設施，在手術量方面處於領先地位。由於人口老化、糖尿病盛行率上升以及血管治療可及性的提高，亞太地區的支架植入術數量正在激增。

支架置入的主要促進因素包括間歇性跛行、危急性肢體缺血和慢性完全阻塞。隨著支架置入程序變得更加簡化且資源密集度降低，該裝置在門診和門診手術中心的應用正在不斷擴大。支架也被納入早期周邊動脈疾病 (PAD) 的管理策略中，以改善功能預後並防止進展為危急性肢體缺血。

周邊支架和植入市場的成長受到多種因素的推動…

周邊支架和植入市場的成長受到許多因素的推動，例如周邊動脈疾病盛行率的上升、支架材料和設計的進步，以及人們對微創血管介入治療的日益偏好。藥物釋放型和自動擴張型支架在臨床上的日益普及，正在改善患者的長期療效，並支持該手術的更廣泛應用。

支架的可視性、靈活性以及與血管動力學相容性的提升提高了手術的安全性。門診血管內治療投入的增加、支持性報銷政策的推行以及介入醫師隊伍的不斷發展，進一步推動了市場擴張。隨著人口老化和血管危險因子的增多，周邊置入術仍然是全球周邊動脈疾病 (PAD) 治療策略的基石。

部分

產品（裸金屬支架、塗層支架、藥物釋放型支架）、最終用戶（醫院最終用戶、門診手術中心/門診最終用戶）、動脈（頸動脈支架、Fem-Pop 動脈支架、髂動脈支架、Infrapop 動脈支架）

受訪公司範例

• Abbott
• Admedes GmbH
• Alvimedica
• B. Braun Melsungen AG
• Bentley InnoMed GmbH
• Biotronik
• Boston Scientific
• Cardinal Health
• Cook Medical
• Cordis
• Endologix LLC
• Gore Medical（WL Gore）
• iVascular
• JOTEC GmbH（CryoLife）
• Medinol
• Medtronic
• MicroPort Scientific
• SMT（Sahajanand Medical Tech）
• Terumo Corporation
• Translumina Therapeutics

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Peripheral Stent Implants Market to Reach US$5.6 Billion by 2030

The global market for Peripheral Stent Implants estimated at US$4.0 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Bare Metal Stents, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Covered Stents segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 9.6% CAGR

The Peripheral Stent Implants market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Peripheral Stent Implants Market - Key Trends & Drivers Summarized

Why Are Peripheral Stent Implants Critical in Restoring Blood Flow in Arterial Disease?

Peripheral stent implants are medical devices used to open narrowed or blocked arteries in the limbs, particularly in cases of peripheral artery disease (PAD). These stents provide structural support to keep vessels open, restore blood circulation, and prevent complications such as tissue ischemia or amputation. They are deployed via catheter-based procedures, offering a minimally invasive alternative to surgical bypass.

PAD is strongly associated with diabetes, smoking, and aging, making stenting a central intervention in vascular medicine. Stents are particularly important in treating femoropopliteal and iliac artery blockages, where traditional angioplasty may not offer long-term patency. Continued refinement in stent design and deployment techniques is improving durability and patient outcomes.

How Are Technologies Advancing for Improved Efficacy and Safety?

Stent innovation is focused on increasing radial strength, flexibility, and long-term patency while minimizing restenosis and fracture. Nitinol-based self-expanding stents are widely used for peripheral vessels due to their adaptability to movement and vessel compression. Drug-eluting stents (DES) and drug-coated stents (DCS) release antiproliferative agents like paclitaxel to reduce the risk of re-narrowing.

Bioabsorbable stents, though still under evaluation, offer the potential for temporary scaffolding with reduced long-term complications. Improved stent delivery systems, low-profile catheters, and imaging-assisted placement tools are enhancing procedural precision. Additionally, new stents designed specifically for challenging anatomies such as below-the-knee (BTK) arteries are supporting expanded treatment indications.

Where Is Market Growth Concentrated and Which Conditions Are Driving Adoption?

Adoption is highest in vascular surgery centers, catheterization labs, and interventional radiology units across developed healthcare systems. North America and Europe lead in procedural volume due to well-established PAD screening and interventional infrastructure. Asia-Pacific is witnessing rapid growth in stent procedures driven by aging populations, increased prevalence of diabetes, and improving access to vascular care.

The primary drivers of stent implantation include intermittent claudication, critical limb ischemia, and chronic total occlusions. Device adoption is expanding in outpatient and ambulatory surgical centers as stenting procedures become more streamlined and less resource-intensive. Early-stage PAD management strategies are also incorporating stents to improve functional outcomes and prevent progression to severe limb ischemia.

Growth in the Peripheral Stent Implants market is driven by several factors…

Growth in the peripheral stent implants market is driven by factors such as rising incidence of peripheral artery disease, advancements in stent material and design, and growing preference for minimally invasive vascular interventions. Expanding clinical use of drug-eluting and self-expanding stents is improving long-term outcomes and supporting broader procedural adoption.

Improvements in stent visibility, flexibility, and compatibility with vessel dynamics are enhancing procedural safety. Increasing investments in outpatient endovascular procedures, supportive reimbursement policies, and training of interventional specialists are further fueling market expansion. As population aging and vascular risk factors continue to rise, peripheral stenting remains a cornerstone of PAD treatment strategies worldwide.

SCOPE OF STUDY:

The report analyzes the Peripheral Stent Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Bare Metal Stents, Covered Stents, Drug Eluting Stents); End-Use (Hospitals End-Use, Ambulatory Surgery Centers / Outpatient End-Use); Artery (Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents, Infrapop Artery Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott
• Admedes GmbH
• Alvimedica
• B. Braun Melsungen AG
• Bentley InnoMed GmbH
• Biotronik
• Boston Scientific
• Cardinal Health
• Cook Medical
• Cordis
• Endologix LLC
• Gore Medical (W. L. Gore)
• iVascular
• JOTEC GmbH (CryoLife)
• Medinol
• Medtronic
• MicroPort Scientific
• SMT (Sahajanand Medical Tech)
• Terumo Corporation
• Translumina Therapeutics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Peripheral Stent Implants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Burden of Peripheral Arterial Disease (PAD) Spurs Demand for Endovascular Stent Implants
  • Growth in Minimally Invasive Interventions Throws the Spotlight on Self-Expanding and Balloon-Expandable Stent Technologies
  • OEM Innovation in Drug-Eluting and Bioabsorbable Peripheral Stents Enhances Long-Term Patency and Reduces Restenosis
  • Expansion of PAD Screening Programs and Aging Population Strengthens Procedural Volumes in Lower Limb Revascularization
  • Improved Imaging and Navigation Systems Support Accurate Stent Deployment in Complex Anatomies
  • OEM Collaboration With Vascular Surgeons Drives Innovation in Tapered and Flexible Stent Platforms
  • Surge in Demand for Below-the-Knee (BTK) and Superficial Femoral Artery (SFA) Stents Expands Device Portfolios
  • Regulatory Approvals and Favorable Clinical Outcomes Fuel Adoption of Next-Generation Peripheral Stents
  • Increased Preference for Ambulatory Vascular Procedures Supports Use of Low-Profile, Deliverable Stent Systems
  • OEM Focus on Radiopaque Markers and Scaffold Design Enhances Intraoperative Precision and Post-Procedure Monitoring
  • Integration of Stent Systems With Drug-Coated Balloons Supports Hybrid Therapy Models for High-Risk Lesions
  • Growing Use of Nitinol and Cobalt-Chromium Materials Enhances Durability and Fracture Resistance
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Peripheral Stent Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Peripheral Stent Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Bare Metal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Carotid Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Fem-Pop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Fem-Pop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Fem-Pop Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Iliac Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Iliac Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Iliac Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Infrapop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Infrapop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Infrapop Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• JAPAN
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• CHINA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• EUROPE
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Peripheral Stent Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• FRANCE
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• GERMANY
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Peripheral Stent Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• INDIA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Peripheral Stent Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Peripheral Stent Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• AFRICA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030

IV. COMPETITION